Application of MED6 genes serving as acute myocardial infarction risk prediction marker
A technology for acute myocardial infarction and risk prediction, applied in the fields of gene diagnosis and biomedicine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0022] The present invention will be further elaborated in conjunction with examples and specific examples, which are only used to explain the present invention, and cannot be construed as limiting the present invention. Those skilled in the art can understand that various changes, modifications, substitutions and modifications can be made to these embodiments without departing from the principle and purpose of the present invention.
[0023] The present invention mainly uses fluorescent quantitative PCR to screen out genes related to acute myocardial infarction, and combines molecular biology experiments and clinical case correlation analysis. It is a marker for the diagnosis and treatment of acute myocardial infarction.
[0024] collection of cases
[0025] According to the global unified definition of myocardial infarction published in 2012. A total of 106 patients who were hospitalized in the Department of Cardiovascular Medicine, China-Japan Friendship Hospital of Jilin...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com